BioSpace News Archive

BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that Dr. Andrei Stoica has been named Chief Technology Officer of the company.

HOYA Corporation and a subsidiary through PENTAX Medical division, Pentax of America, Inc. (collectively, “PENTAX” or “the Company”), today finalized a Deferred Prosecution Agreement (DPA) with the U.S. Department of Justice (DOJ) on issues related to the timely filing of Medical Device Reports (MDRs) for PENTAX Medical’s duodenoscopes

Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 766,667 shares of the Company’s common stock, at a purchase price of $6.00 per share, in a registered direct offering priced at-the-market under Nasdaq rules

Medical publisher Healio, announces the launch of the new publication, Healio Psoriatic Disease

Canadian businesses and manufacturers are stepping up in the fight against the COVID-19 pandemic.

The National Kidney Registry and Viracor Eurofins announced a partnership to deliver the newly released COVID-19 antibody testing for NKR’s vast network of Member Centers.

As cited in hundreds of peer reviewed publications, naturally occurring nitric oxide in the nasal cavities is a primary defense in humans that is needed to kill invading bacteria, fungi and viruses.

Polarity Medical recently announced it has developed patent-pending designs for multiple UV-C light Automatic Sterilizing devices to help combat the spread of viruses, bacteria and other disease-causing pathogens.

Leading molecular diagnostic company’s new hire to support oncology product development strategy through leadership and medical guidance

EpiVax, Inc., is using advanced computational tools to accelerate a COVID-19 vaccine candidate for healthcare workers into clinical trials in 6 months.